Genky DrugStores Co., Ltd. (TYO:9267)
Japan · Delayed Price · Currency is JPY 3,625.00
+45.00 (1.26%)
Aug 6, 2026, 10:42 AM JST
Genky DrugStores Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Cash & Equivalents | 7,866 | 6,221 | 5,896 | 5,329 | 5,438 |
Cash & Short-Term Investments | 7,866 | 6,221 | 5,896 | 5,329 | 5,438 |
Cash Growth | 26.44% | 5.51% | 10.64% | -2.00% | -31.28% |
Accounts Receivable | 5,667 | 4,837 | 4,685 | 3,925 | 2,799 |
Other Receivables | 3,413 | 2,575 | 2,406 | 2,259 | 2,014 |
Receivables | 9,080 | 7,412 | 7,091 | 6,184 | 4,813 |
Inventory | 28,654 | 27,071 | 24,028 | 22,490 | 20,911 |
Other Current Assets | 521 | 506 | 319 | 410 | 352 |
Total Current Assets | 46,121 | 41,210 | 37,334 | 34,413 | 31,514 |
Property, Plant & Equipment | 91,866 | 79,203 | 69,936 | 65,104 | 59,260 |
Long-Term Investments | 90 | 3,857 | 3,760 | 3,637 | 3,680 |
Other Intangible Assets | 266 | 307 | 378 | 363 | 374 |
Long-Term Deferred Tax Assets | 2,376 | 2,120 | 2,039 | 1,840 | 1,698 |
Other Long-Term Assets | 4,277 | 2 | 2 | 1 | 1 |
Total Assets | 145,598 | 127,326 | 113,939 | 105,912 | 97,118 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Accounts Payable | 36,079 | 26,732 | 24,188 | 22,192 | 20,564 |
Accrued Expenses | 103 | 121 | 133 | 136 | 105 |
Current Portion of Long-Term Debt | 9,481 | 8,412 | 8,088 | 11,242 | 10,180 |
Current Portion of Leases | 6 | 6 | 7 | 19 | 17 |
Current Income Taxes Payable | 2,254 | 7,132 | 6,939 | 5,467 | 5,594 |
Current Unearned Revenue | 596 | - | - | - | - |
Other Current Liabilities | 1,190 | 1,409 | 1,491 | 1,060 | 1,187 |
Total Current Liabilities | 49,709 | 43,812 | 40,846 | 40,116 | 37,647 |
Long-Term Debt | 30,020 | 25,817 | 22,408 | 20,946 | 20,754 |
Long-Term Leases | 133 | 139 | 145 | 147 | 8 |
Other Long-Term Liabilities | 4,363 | 4,131 | 3,861 | 4,023 | 2,477 |
Total Liabilities | 84,225 | 73,899 | 67,260 | 65,232 | 60,886 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Common Stock | 1,085 | 1,035 | 1,024 | 1,010 | 1,008 |
Additional Paid-In Capital | 6,746 | 6,451 | 6,440 | 6,426 | 6,424 |
Retained Earnings | 54,013 | 46,534 | 39,862 | 33,917 | 29,531 |
Treasury Stock | -699 | -790 | -790 | -789 | -789 |
Comprehensive Income & Other | 228 | 197 | 143 | 116 | 58 |
Shareholders' Equity | 61,373 | 53,427 | 46,679 | 40,680 | 36,232 |
Total Liabilities & Equity | 145,598 | 127,326 | 113,939 | 105,912 | 97,118 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Total Debt | 39,640 | 34,374 | 30,648 | 32,354 | 30,959 |
Net Cash (Debt) | -31,774 | -28,153 | -24,752 | -27,025 | -25,521 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -1039.77 | -924.42 | -813.77 | -889.27 | -839.63 |
Filing Date Shares Outstanding | 30.51 | 30.4 | 30.38 | 30.37 | 30.37 |
Total Common Shares Outstanding | 30.51 | 30.4 | 30.38 | 30.37 | 30.37 |
Working Capital | -3,588 | -2,602 | -3,512 | -5,703 | -6,133 |
Book Value Per Share | 2011.77 | 1757.70 | 1536.31 | 1339.57 | 1193.22 |
Tangible Book Value | 61,107 | 53,120 | 46,301 | 40,317 | 35,858 |
Tangible Book Value Per Share | 2003.06 | 1747.60 | 1523.87 | 1327.62 | 1180.90 |